HCPCS code lookup
HCPCS Level II
Q2042
Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Ask Rivvi
- Code
- Q2042
- Description
- Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
NDC crosswalk
- 00078-0846-19 Kymriah, Novartis Pharmaceuticals Corporation. Billable units per 11-digit NDC: 1.
- 00078-0958-19 Kymriah, Novartis Pharmaceuticals Corporation. Billable units per 11-digit NDC: 1.
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.